Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.
Recent insider activity at Recursion Pharmaceuticals Inc included 2 stock sales totaling $256,000 and 2 stock awards with no reported dollar value. All 4 transactions were filed by directors or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results